SELLAS Life Sciences Group, Inc. (SLS)
4.46
-0.18
(-3.88%)
USD |
NASDAQ |
Apr 24, 16:00
4.61
+0.15
(+3.36%)
After-Hours: 20:00
SELLAS Life Sciences Group EPS Diluted (Quarterly) : -0.05 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Spero Therapeutics, Inc. | 0.5309 |
| Recursion Pharmaceuticals, Inc. | -0.2053 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.658M |
| Total Expenses (Quarterly) | 7.658M |
| Enterprise Value | 730.05M |
| Earnings Yield | -5.51% |
| Normalized Earnings Yield | -5.514 |